10. The Hopewell Pharmaceutical Company's balance sheet and income statement for last year are as follows: Balance Sheet (in Millions of Dollars) Assets Liabilities and Equity Cash and marketable $1,100 Accounts payable*** $900 securities Accounts receivable* 1,300 Accrued liabilities Inventories** 800 (salaries and benefits) 300 Other current assets 200 Other current liabilities 700 Total current assets $3,400 Total current liabilities $1,900 Plant and equipment (net) 2,300 Long-term debt and other Other assets 1,000 liabilities 1,000 Total assets $6,700 Common stock 1,800 Retained earnings 2,000

EBK CONTEMPORARY FINANCIAL MANAGEMENT
14th Edition
ISBN:9781337514835
Author:MOYER
Publisher:MOYER
Chapter3: Evaluation Of Financial Performance
Section: Chapter Questions
Problem 19P
icon
Related questions
Question
10. The Hopewell Pharmaceutical Company's balance sheet and income statement for
last year are as follows:
CHALLENGE
Balance Sheet (in Millions of Dollars)
Assets
Liabilities and Equity
Cash and marketable
$1,100
Accounts payable***
$900
securities
Accounts receivable*
1,300
Accrued liabilities
Inventories**
800
(salaries and benefits)
300
Other current assets
200
Other current liabilities
700
Total current assets
$3,400
Total current liabilities
$1,900
Plant and equipment (net)
2,300
Long-term debt and other
Other assets
1,000
liabilities
1,000
Total assets
$6,700
Common stock
1,800
Retained eamings
2,000
Total stockholders" equity
$3,800
Total liabilities and equity
$6,700
*Assume that average accounts receivable are the same as ending accounts receivable.
**Assume that average inventory over the year was the same as ending inventory.
***Assume that average accounts payable are the same as ending accounts payable.
Income Statement (in Millions of Dollars)
Net sales
$6,500
Cost of sales
1,500
Selling, general, and administrative expenses
2,500
Other expenses
800
Total expenses
$4,800
Eamings before taxes
1,700
Тахes
680
Earmings after taxes (net income)
$1,020
a. Determine Hopewell's cash conversion cycle.
b. Give an interpretation of the value computed in Part a.
Transcribed Image Text:10. The Hopewell Pharmaceutical Company's balance sheet and income statement for last year are as follows: CHALLENGE Balance Sheet (in Millions of Dollars) Assets Liabilities and Equity Cash and marketable $1,100 Accounts payable*** $900 securities Accounts receivable* 1,300 Accrued liabilities Inventories** 800 (salaries and benefits) 300 Other current assets 200 Other current liabilities 700 Total current assets $3,400 Total current liabilities $1,900 Plant and equipment (net) 2,300 Long-term debt and other Other assets 1,000 liabilities 1,000 Total assets $6,700 Common stock 1,800 Retained eamings 2,000 Total stockholders" equity $3,800 Total liabilities and equity $6,700 *Assume that average accounts receivable are the same as ending accounts receivable. **Assume that average inventory over the year was the same as ending inventory. ***Assume that average accounts payable are the same as ending accounts payable. Income Statement (in Millions of Dollars) Net sales $6,500 Cost of sales 1,500 Selling, general, and administrative expenses 2,500 Other expenses 800 Total expenses $4,800 Eamings before taxes 1,700 Тахes 680 Earmings after taxes (net income) $1,020 a. Determine Hopewell's cash conversion cycle. b. Give an interpretation of the value computed in Part a.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps

Blurred answer
Knowledge Booster
Ratio Analysis
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
EBK CONTEMPORARY FINANCIAL MANAGEMENT
EBK CONTEMPORARY FINANCIAL MANAGEMENT
Finance
ISBN:
9781337514835
Author:
MOYER
Publisher:
CENGAGE LEARNING - CONSIGNMENT
Intermediate Accounting: Reporting And Analysis
Intermediate Accounting: Reporting And Analysis
Accounting
ISBN:
9781337788281
Author:
James M. Wahlen, Jefferson P. Jones, Donald Pagach
Publisher:
Cengage Learning
Cornerstones of Financial Accounting
Cornerstones of Financial Accounting
Accounting
ISBN:
9781337690881
Author:
Jay Rich, Jeff Jones
Publisher:
Cengage Learning
EBK CFIN
EBK CFIN
Finance
ISBN:
9781337671743
Author:
BESLEY
Publisher:
CENGAGE LEARNING - CONSIGNMENT
Survey of Accounting (Accounting I)
Survey of Accounting (Accounting I)
Accounting
ISBN:
9781305961883
Author:
Carl Warren
Publisher:
Cengage Learning
Intermediate Financial Management (MindTap Course…
Intermediate Financial Management (MindTap Course…
Finance
ISBN:
9781337395083
Author:
Eugene F. Brigham, Phillip R. Daves
Publisher:
Cengage Learning